Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Rheumatoid Arthritis

Free Subscription Articles published in Rheumatol Int Retrieve available abstracts of 218 articles: HTML format

Single Articles

December 2024
1. BOURNIA VK, Fragoulis GE, Mitrou P, Tsolakidis A, et al
   Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.
   Rheumatol Int. 2024;44:2837-2846.
   PubMed     Abstract available
   
   
   
2. XU Z, Han T, Cheng L, Fan J, et al
   The real experience of reporting electronic patient-reported outcomes in patients with inflammatory arthritis and factors influencing participation: a scoping review.
   Rheumatol Int. 2024;44:2795-2806.
   PubMed     Abstract available
   
   
   
3. ANTON J, Mosquera JM, Calzada J, Iglesias E, et al
   Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.
   Rheumatol Int. 2024;44:2911-2920.
   PubMed     Abstract available
   
   
   
4. PRASAD CB, Kopp CR, Naidu G, Sharma V, et al
   Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjogren's syndrome: a systematic review of individual patient data.
   Rheumatol Int. 2024;44:2807-2815.
   PubMed     Abstract available
   
   
   November 2024
5. LEE JS, Oh JS, Kim S, Kim YJ, et al
   The association of obesity and the risk of rheumatoid arthritis according to abdominal obesity status: a nationwide population-based study in Korea.
   Rheumatol Int. 2024 Nov 22. doi: 10.1007/s00296-024-05748.
   PubMed     Abstract available
   
   
   
6. GULA Z, Losinska K, Kuszmiersz P, Strach M, et al
   A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.
   Rheumatol Int. 2024 Nov 11. doi: 10.1007/s00296-024-05740.
   PubMed     Abstract available
   
   
   
7. DEY M, Doskaliuk B, Parodis I, Lindblom J, et al
   COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
   Rheumatol Int. 2024 Nov 6. doi: 10.1007/s00296-024-05742.
   PubMed     Abstract available
   
   
   October 2024
8. UHRENHOLT L, Sorensen MER, Lauridsen KB, Duch K, et al
   Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
   Rheumatol Int. 2024;44:1897-1908.
   PubMed     Abstract available
   
   
   
9. HINKEMA HJ, Westra J, Arends S, Brouwer E, et al
   Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study.
   Rheumatol Int. 2024;44:2007-2016.
   PubMed     Abstract available
   
   
   
10. NIELLY H, Biale L, Gilardin L, Carmoi T, et al
    Tocilizumab-induced psoriatic eruption : a case report and a case-based review.
    Rheumatol Int. 2024;44:2205-2212.
    PubMed     Abstract available
    
    
    September 2024
11. XIE W, Huang H, Geng Y, Fan Y, et al
    Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China.
    Rheumatol Int. 2024 Sep 12. doi: 10.1007/s00296-024-05713.
    PubMed     Abstract available
    
    
    
12. KOSCINSKA-SHUKLA I, Jaskolska M, Chylinska M, Jaskolski D, et al
    Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sjogren syndrome - a prospective observational study on 50 patients.
    Rheumatol Int. 2024;44:1739-1747.
    PubMed     Abstract available
    
    
    
13. DE OLIVEIRA JL, Cordeiro RA, Guedes LKN, Pasoto SG, et al
    Shrinking lung syndrome in primary Sjogren's syndrome: a case-based review.
    Rheumatol Int. 2024;44:1795-1800.
    PubMed     Abstract available
    
    
    August 2024
14. TERMINE M, Davidson Z, Choi T, Leech M, et al
    What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping review.
    Rheumatol Int. 2024 Aug 27. doi: 10.1007/s00296-024-05691.
    PubMed     Abstract available
    
    
    
15. SCHAFER VS, Winter L, Skowasch D, Bauer CJ, et al
    Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study.
    Rheumatol Int. 2024 Aug 21. doi: 10.1007/s00296-024-05685.
    PubMed     Abstract available
    
    
    
16. SAGTAGANOV Z, Bekaryssova D
    Complex rehabilitation of patients with rheumatoid arthritis.
    Rheumatol Int. 2024 Aug 3. doi: 10.1007/s00296-024-05669.
    PubMed     Abstract available
    
    
    July 2024
17. HERMANN S, Palmowski A, Hermann KGA, Muche B, et al
    Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2024 Jul 29. doi: 10.1007/s00296-024-05655.
    PubMed     Abstract available
    
    
    
18. MAHAJAN A, Mruthyunjaya P, Padhee S, Ahmed S, et al
    People with osteoarthritis have a higher component of neuropathic pain as compared to those with rheumatoid arthritis: A cross-sectional study.
    Rheumatol Int. 2024 Jul 12. doi: 10.1007/s00296-024-05657.
    PubMed     Abstract available
    
    
    
19. SALEEM RA, Ramadan M, Elshaaer Y, Sukkarieh H, et al
    Laboratory features and pharmacological management of early and late-onset primary Sjogren's syndrome.
    Rheumatol Int. 2024;44:1317-1325.
    PubMed     Abstract available
    
    
    
20. ARYA PVA, Marnet E, Rondla M, Tan JW, et al
    Renal manifestations in adult-onset Still's disease: a systematic review.
    Rheumatol Int. 2024;44:1209-1218.
    PubMed     Abstract available
    
    
    
21. POPOVA V, Geneva-Popova M, Popova-Belova S, Doykov M, et al
    Diagnostic and prognostic role of serum interleukin-6 and carotid ultrasonography to detect subclinical atherosclerosis in patients with RA and ANCA-associated vasculitis.
    Rheumatol Int. 2024;44:1295-1303.
    PubMed     Abstract available
    
    
    
22. BOTABEKOVA A, Baimukhamedov C, Zimba O, Mehta P, et al
    Examining the clinical and radiological landscape of rhupus: navigating the challenges in disease classification.
    Rheumatol Int. 2024;44:1185-1196.
    PubMed     Abstract available
    
    
    
23. FEDORCHENKO Y, Zimba O, Yatsyshyn R, Doskaliuk B, et al
    The interplay between rheumatic diseases and pulmonary health.
    Rheumatol Int. 2024;44:1179-1184.
    PubMed     Abstract available
    
    
    
24. PASOTO SG, Villamarin LEB, de Vinci Kanda Kupa L, Deveza GBH, et al
    Assessment of hydroxychloroquine blood levels in Sjogren's disease patients: drug adherence and clinical associations.
    Rheumatol Int. 2024;44:1305-1315.
    PubMed     Abstract available
    
    
    June 2024
25. SERNA-PENA G, Flores-Gutierrez DP, Vega-Sevilla LF, Villarreal-Saenz MA, et al
    Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional survey.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05648.
    PubMed     Abstract available
    
    
    
26. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D, Suigenbayev D, et al
    Managing rheumatoid arthritis and cardiovascular disease: the role of physical medicine and rehabilitation.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05651.
    PubMed     Abstract available
    
    
    
27. BAKKER NF, van Weely SFE, Boonen A, Vliet Vlieland TPM, et al
    Work-related support for employed and self-employed people with rheumatoid arthritis or axial spondyloarthritis: a cross-sectional online survey of patients.
    Rheumatol Int. 2024 Jun 20. doi: 10.1007/s00296-024-05643.
    PubMed     Abstract available
    
    
    
28. RAMOS-PETERSEN L, Reinoso-Cobo A, Ortega-Avila AB, Garcia-Campos J, et al
    A clinical practice guideline for the management of the foot and ankle in rheumatoid arthritis.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05633.
    PubMed     Abstract available
    
    
    
29. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D
    Yoga as a complementary therapy for rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05641.
    PubMed     Abstract available
    
    
    
30. CONTRERAS DG, McLane P, Barber CEH, Lin K, et al
    Emergency department utilization by persons with rheumatoid arthritis: a population-based cohort study.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05627.
    PubMed     Abstract available
    
    
    
31. PETZINNA SM, Winter L, Skowasch D, Pizarro C, et al
    Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study.
    Rheumatol Int. 2024;44:1025-1034.
    PubMed     Abstract available
    
    
    May 2024
32. SWEENEY M, Adas MA, Cope A, Norton S, et al
    Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review.
    Rheumatol Int. 2024 May 22. doi: 10.1007/s00296-024-05574.
    PubMed     Abstract available
    
    
    April 2024
33. KRAJEWSKA-WLODARCZYK M, Szelag M, Batko B, Zuber Z, et al
    Rheumatoid arthritis epidemiology: a nationwide study in Poland.
    Rheumatol Int. 2024 Apr 27. doi: 10.1007/s00296-024-05591.
    PubMed     Abstract available
    
    
    
34. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
    Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
    Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
    PubMed     Abstract available
    
    
    
35. LINDGREN LH, de Thurah A, Thomsen T, Hetland ML, et al
    Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
    Rheumatol Int. 2024 Apr 2. doi: 10.1007/s00296-024-05553.
    PubMed     Abstract available
    
    
    
36. FEDORCHENKO Y, Mahmudov K, Abenov Z, Zimba O, et al
    Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs.
    Rheumatol Int. 2024;44:583-591.
    PubMed     Abstract available
    
    
    
37. ASMAR S, Messaykeh J, Hilal N, Rida MA, et al
    Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
    Rheumatol Int. 2024;44:725-736.
    PubMed     Abstract available
    
    
    March 2024
38. GRANT WB
    The present understanding of the effects of dietary red meat and the Mediterranean diet on rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 27. doi: 10.1007/s00296-024-05587.
    PubMed    
    
    
    
39. KALETA K, Krupa J, Suchy W, Sopel A, et al
    Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 24. doi: 10.1007/s00296-024-05556.
    PubMed     Abstract available
    
    
    
40. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
    Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
    Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
    PubMed     Abstract available
    
    
    
41. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
    Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
    Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
    PubMed     Abstract available
    
    
    
42. LARKIN L, McKenna S, Pyne T, Comerford P, et al
    Promoting physical activity in rheumatoid arthritis through a physiotherapist led behaviour change-based intervention (PIPPRA): a feasibility randomised trial.
    Rheumatol Int. 2024 Mar 4. doi: 10.1007/s00296-024-05544.
    PubMed     Abstract available
    
    
    
43. DURUOZ MT, Nas K, Kasman SA, Oz N, et al
    Validity and reliability of the Duruoz Hand Index in patients with psoriatic arthritis.
    Rheumatol Int. 2024;44:535-542.
    PubMed     Abstract available
    
    
    
44. COSKUN BN, Yagiz B, Ocakoglu G, Dalkilic E, et al
    Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.
    Rheumatol Int. 2024;44:509-515.
    PubMed     Abstract available
    
    
    
45. COX N, Hawarden A, Bajpai R, Farooq S, et al
    The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.
    Rheumatol Int. 2024;44:435-440.
    PubMed     Abstract available
    
    
    
46. KAMINSKI M, Hrycaj P
    Celebrities influence on rheumatic diseases interest: a Google Trends analysis.
    Rheumatol Int. 2024;44:517-521.
    PubMed     Abstract available
    
    
    February 2024
47. SHARMA P, Brown S, Sokoya EM
    Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
    Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
    PubMed     Abstract available
    
    
    January 2024
48. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
    Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
    PubMed     Abstract available
    
    
    
49. COUREL-IBANEZ J, Vetrovsky T, Ruzickova N, Maranon C, et al
    Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
    Rheumatol Int. 2024 Jan 5. doi: 10.1007/s00296-023-05507.
    PubMed     Abstract available
    
    
    
50. MORALIYSKA R, Georgiev T, Bogdanova-Petrova S, Shivacheva T, et al
    Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
    Rheumatol Int. 2024;44:165-172.
    PubMed     Abstract available
    
    
    December 2023
51. DURUOZ MT, Ataman S, Bodur H, Cay HF, et al
    Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
    Rheumatol Int. 2023 Dec 29. doi: 10.1007/s00296-023-05515.
    PubMed     Abstract available
    
    
    
52. DUBEY S, Woodhead F
    Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
    Rheumatol Int. 2023 Dec 12. doi: 10.1007/s00296-023-05505.
    PubMed     Abstract available
    
    
    November 2023
53. TEUWEN MMH, Vlieland TPMV, van Weely SFE, Schoones JW, et al
    Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.
    Rheumatol Int. 2023 Nov 30. doi: 10.1007/s00296-023-05502.
    PubMed     Abstract available
    
    
    
54. TEUWEN MMH, van Weely SFE, Vliet Vlieland TPM, Douw T, et al
    Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.
    Rheumatol Int. 2023 Nov 25. doi: 10.1007/s00296-023-05487.
    PubMed     Abstract available
    
    
    
55. MIHAYLOVA V, Kazakova M, Batalov Z, Karalilova R, et al
    JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2023 Nov 20. doi: 10.1007/s00296-023-05501.
    PubMed     Abstract available
    
    
    
56. DE FIGUEIREDO LQ, de Andrade Lopes FO, Franco AS, Giardini HAM, et al
    Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2023 Nov 4. doi: 10.1007/s00296-023-05494.
    PubMed     Abstract available
    
    
    
57. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
    Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
    Rheumatol Int. 2023;43:2057-2064.
    PubMed     Abstract available
    
    
    
58. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
    The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
    Rheumatol Int. 2023;43:2031-2036.
    PubMed     Abstract available
    
    
    October 2023
59. COSKUN BENLIDAYI I
    Exercise therapy for improving cardiovascular health in rheumatoid arthritis.
    Rheumatol Int. 2023 Oct 31. doi: 10.1007/s00296-023-05492.
    PubMed     Abstract available
    
    
    
60. KOUNATIDIS DC, Papadimitropoulos V, Avramidis K, Plenga E, et al
    Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review.
    Rheumatol Int. 2023 Oct 18. doi: 10.1007/s00296-023-05483.
    PubMed     Abstract available
    
    
    
61. FLOURI I, Goutakoli P, Repa A, Bertsias A, et al
    Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
    Rheumatol Int. 2023 Oct 10. doi: 10.1007/s00296-023-05455.
    PubMed     Abstract available
    
    
    
62. THOMSEN T, Aadahl M, Hetland ML, Esbensen BA, et al
    Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
    Rheumatol Int. 2023 Oct 3. doi: 10.1007/s00296-023-05466.
    PubMed     Abstract available
    
    
    
63. VAN SLINGERLAND K, de Jong PHP, Dolhain RJEM, Pasma A, et al
    The effect of a goal-setting strategy with integrated feedback on goal attainment in inflammatory arthritis patients: a mixed method study.
    Rheumatol Int. 2023;43:1897-1904.
    PubMed     Abstract available
    
    
    September 2023
64. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05458.
    PubMed     Abstract available
    
    
    
65. SULLI A, Clini P, Bruzzone G, Signori A, et al
    An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
    Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
    PubMed     Abstract available
    
    
    
66. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
    Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
    Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
    PubMed     Abstract available
    
    
    August 2023
67. BHAT SS, Ahmed S, Reji R, Mehta P, et al
    Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial.
    Rheumatol Int. 2023 Aug 31. doi: 10.1007/s00296-023-05417.
    PubMed     Abstract available
    
    
    
68. AL-MAINI M, Maindarkar M, Kitas GD, Khanna NN, et al
    Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a narrative review.
    Rheumatol Int. 2023 Aug 30. doi: 10.1007/s00296-023-05415.
    PubMed     Abstract available
    
    
    
69. MATHIEU S, Lambert C, Fayet F, Couderc M, et al
    Comparison of the cardiovascular risk profile of rheumatoid arthritis versus hand osteoarthritis patients.
    Rheumatol Int. 2023 Aug 11. doi: 10.1007/s00296-023-05405.
    PubMed     Abstract available
    
    
    July 2023
70. SUARDI I, Posio C, Luconi E, Boracchi P, et al
    Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study.
    Rheumatol Int. 2023 Jul 16. doi: 10.1007/s00296-023-05383.
    PubMed     Abstract available
    
    
    
71. RAAD T, Griffin A, George ES, Larkin L, et al
    Experience and perceptions among rheumatoid arthritis patients following a telehealth-delivered dietary intervention: a qualitative study.
    Rheumatol Int. 2023 Jul 7. doi: 10.1007/s00296-023-05382.
    PubMed     Abstract available
    
    
    
72. ATHANASSIOU P, Psaltis D, Georgiadis A, Katsifis G, et al
    Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.
    Rheumatol Int. 2023 Jul 5. doi: 10.1007/s00296-023-05376.
    PubMed     Abstract available
    
    
    
73. GASTELUM-STROZZI A, Flores-Alvarado DE, Pascual-Ramos V, Alvarez-Hernandez E, et al
    The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study.
    Rheumatol Int. 2023;43:1253-1264.
    PubMed     Abstract available
    
    
    
74. FELIS-GIEMZA A, Chmurzynska K, Kolodziejczyk B, Gazda A, et al
    Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
    Rheumatol Int. 2023;43:1307-1311.
    PubMed     Abstract available
    
    
    
75. CHATTERJEE R, Balakrishnan A, Kharbanda R, Rathore U, et al
    Renal involvement in Sjogren's syndrome: predictors and impact on patient outcomes.
    Rheumatol Int. 2023;43:1297-1306.
    PubMed     Abstract available
    
    
    June 2023
76. WROBEL A, Baranska I, Szklarczyk J, Majda A, et al
    Relationship between perceived stress, stress coping strategies, and clinical status in patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 18. doi: 10.1007/s00296-023-05367.
    PubMed     Abstract available
    
    
    
77. VICTORIA MA, Lucio VR, Cristina HD
    Patient self-reported instruments for assessing symptoms in rheumatoid arthritis.
    Rheumatol Int. 2023 Jun 15. doi: 10.1007/s00296-023-05355.
    PubMed     Abstract available
    
    
    
78. GARCIA-SALINAS R, Sanchez-Prado E, Mareco J, Ronald P, et al
    Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations.
    Rheumatol Int. 2023 Jun 3. doi: 10.1007/s00296-023-05349.
    PubMed     Abstract available
    
    
    
79. ERMEIDIS C, Dimitroulas T, Pourzitaki C, Voulgari PV, et al
    Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.
    Rheumatol Int. 2023;43:1151-1159.
    PubMed     Abstract available
    
    
    
80. URHAN E, Urhan AC, Dogan HO, Sahin A, et al
    Assessment of semaphorin 3A and semaphorin 7A levels in primary Sjogren's syndrome.
    Rheumatol Int. 2023;43:1087-1092.
    PubMed     Abstract available
    
    
    May 2023
81. O'BRIEN CM, Kitas GD, Rayner F, Isaacs JD, et al
    Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study.
    Rheumatol Int. 2023 May 25. doi: 10.1007/s00296-023-05342.
    PubMed     Abstract available
    
    
    
82. VENETSANOPOULOU AI, Alamanos Y, Voulgari PV, Drosos AA, et al
    Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980-2019.
    Rheumatol Int. 2023 May 13. doi: 10.1007/s00296-023-05325.
    PubMed    
    
    
    April 2023
83. VAN DEN HOEK J, Sobejana M, van Nes F, Metsios G, et al
    Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05312.
    PubMed     Abstract available
    
    
    
84. AUSSERWINKLER M, Neumann HJ, Wernly B
    Rheumatoid arthritis and cardiovascular risk: keep it simple and compassionate.
    Rheumatol Int. 2023 Apr 24. doi: 10.1007/s00296-023-05333.
    PubMed    
    
    
    
85. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    Adherence to biological therapies in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Apr 19. doi: 10.1007/s00296-023-05327.
    PubMed     Abstract available
    
    
    
86. KODURI GM, Podlasek A, Pattapola S, Zhang J, et al
    Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis.
    Rheumatol Int. 2023 Apr 18. doi: 10.1007/s00296-023-05313.
    PubMed     Abstract available
    
    
    
87. SEPPEN BF, Wiegel J, Nurmohamed MT, Bos WH, et al
    Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis.
    Rheumatol Int. 2023;43:677-685.
    PubMed     Abstract available
    
    
    
88. WILK M, Pripp AH, Korkosz M, Haugeberg G, et al
    Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Rheumatol Int. 2023;43:687-694.
    PubMed     Abstract available
    
    
    
89. OTON T, Carmona L, Andreu JL
    What do patients on methotrexate need and expect at the clinic? An online patient survey.
    Rheumatol Int. 2023;43:735-741.
    PubMed     Abstract available
    
    
    
90. MUEHLENSIEPEN F, May S, Hadaschik K, Vuillerme N, et al
    Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.
    Rheumatol Int. 2023;43:695-703.
    PubMed     Abstract available
    
    
    
91. TANAKA Y, Barrett C, Hirano Y, Ikeda K, et al
    Management of chronic rheumatic diseases in women 18-45 years of age in Asia Pacific: insights from patient and clinician surveys.
    Rheumatol Int. 2023;43:721-733.
    PubMed     Abstract available
    
    
    
92. LI Y, Berianu F, Brumble L, Calamia KT, et al
    Synovitis due to Histoplasma capsulatum: a case series and literature review.
    Rheumatol Int. 2023;43:763-769.
    PubMed     Abstract available
    
    
    
93. OZSOY Z, Ozdemir A, Ekici M, Bilgin E, et al
    Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Rheumatol Int. 2023 Apr 1. doi: 10.1007/s00296-023-05320.
    PubMed     Abstract available
    
    
    March 2023
94. VENETSANOPOULOU AI, Kalpourtzi N, Alamanos Y, Gavana M, et al
    Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO.
    Rheumatol Int. 2023 Mar 31. doi: 10.1007/s00296-023-05316.
    PubMed     Abstract available
    
    
    
95. DHIR V, Prasad CB, Kumar S, Kaul KK, et al
    Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2023 Mar 18. doi: 10.1007/s00296-023-05305.
    PubMed     Abstract available
    
    
    
96. LOSINSKA K, Korkosz M, Pripp AH, Haugeberg G, et al
    Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naive to or switched from reference rituximab.
    Rheumatol Int. 2023 Mar 16. doi: 10.1007/s00296-023-05307.
    PubMed     Abstract available
    
    
    
97. WROBEL A, Szklarczyk J, Baranska I, Majda A, et al
    Association between levels of serotonin, melatonin, cortisol and the clinical condition of patients with rheumatoid arthritis.
    Rheumatol Int. 2023 Mar 13. doi: 10.1007/s00296-023-05296.
    PubMed     Abstract available
    
    
    
98. PARPERIS K, Achilleos S, Costi E, Vardas M, et al
    Autoimmune rheumatic diseases associated with granulomatous mastitis.
    Rheumatol Int. 2023;43:399-407.
    PubMed     Abstract available
    
    
    
99. FRADE-SOSA B, Azuaga AB, Ruiz-Esquide V, Gomez-Puerta JA, et al
    Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report.
    Rheumatol Int. 2023;43:533-536.
    PubMed     Abstract available
    
    
    
100. CAPKIN E, Yazici A, Karkucak M, Durmaz Y, et al
     Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study.
     Rheumatol Int. 2023;43:523-531.
     PubMed     Abstract available
     
     
     February 2023
101. CHARLES-SCHOEMAN C, Wang J, Shahbazian A, Wilhalme H, et al
     Power doppler ultrasound signal predicts abnormal HDL function in patients with rheumatoid arthritis.
     Rheumatol Int. 2023 Feb 24. doi: 10.1007/s00296-023-05285.
     PubMed     Abstract available
     
     
     
102. KOSTER F, Bakx PLH, Kok MR, Barreto DL, et al
     Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison.
     Rheumatol Int. 2023 Feb 10. doi: 10.1007/s00296-023-05282.
     PubMed     Abstract available
     
     
     
103. PARASCHOU V, Partalidou S, Siolos P, Papadopoulou Z, et al
     Prevalence of hearing loss in patients with Sjogren syndrome: a systematic review and meta-analysis.
     Rheumatol Int. 2023;43:233-244.
     PubMed     Abstract available
     
     
     
104. YOLCU G, Abacar KY, Kenis-Coskun O, Nevsun-Inanc G, et al
     Comparison of cutaneous silent period parameters in patients with primary Sjogren's syndrome with the healthy population and determination of its relationship with clinical parameters.
     Rheumatol Int. 2023;43:355-362.
     PubMed     Abstract available
     
     
     January 2023
105. WIEGEL J, Seppen BF, Nurmohamed MT, Ter Wee MM, et al
     Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.
     Rheumatol Int. 2023 Jan 30:1-7. doi: 10.1007/s00296-023-05278.
     PubMed     Abstract available
     
     
     
106. ELFVING P, Kononoff A, Huhtakangas J, Kautiainen H, et al
     Incidence of seropositive rheumatoid arthritis in population-based studies in Northern Savo, Finland, during 1980-2020.
     Rheumatol Int. 2023 Jan 11:1-8. doi: 10.1007/s00296-022-05268.
     PubMed     Abstract available
     
     
     
107. GHEITA TA, Raafat HA, El-Bakry SA, Elsaman A, et al
     Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance.
     Rheumatol Int. 2023 Jan 8. doi: 10.1007/s00296-022-05258.
     PubMed     Abstract available
     
     
     
108. BALAKRISHNAN A, Majumder S, Guleria S, Lawrence A, et al
     Macrophage migration inhibitory factor (MIF) and IgA anti CD74 antibodies in Indian patients with enthesitis-related arthritis category of Juvenile idiopathic arthritis.
     Rheumatol Int. 2023;43:157-162.
     PubMed     Abstract available
     
     
     December 2022
109. KOCYIGIT BF, Sagtaganov Z, Yessirkepov M, Akyol A, et al
     Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome.
     Rheumatol Int. 2022 Dec 30:1-9. doi: 10.1007/s00296-022-05267.
     PubMed     Abstract available
     
     
     
110. SANAL-TOPRAK C, Unal-Ulutatar C, Duruoz E, Oz N, et al
     The validity and reliability of the Turkish version of the Arthritis Impact Measurement Scale 2-Short Form (AIMS2-SF) for rheumatoid arthritis.
     Rheumatol Int. 2022 Dec 11. doi: 10.1007/s00296-022-05257.
     PubMed     Abstract available
     
     
     
111. VIDEM V, Houge IS, Hoff M
     Persons with rheumatoid arthritis have higher barriers to physical activity than controls: a cross-sectional study using the Facilitators and Barriers to Physical Activity Questionnaire (FasBarPAQ).
     Rheumatol Int. 2022 Dec 7. doi: 10.1007/s00296-022-05252.
     PubMed     Abstract available
     
     
     
112. FEDKOV D, Berghofen A, Weiss C, Peine C, et al
     Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot study.
     Rheumatol Int. 2022;42:2177-2190.
     PubMed     Abstract available
     
     
     
113. CHEN J, He Q, Jiang B, Song W, et al
     Research on primary Sjogren's syndrome in 2004-2021: a Web of Science-based cross-sectional bibliometric analysis.
     Rheumatol Int. 2022;42:2221-2229.
     PubMed     Abstract available
     
     
     November 2022
114. ZOUBI T, Gordon H
     Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity.
     Rheumatol Int. 2022 Nov 30. doi: 10.1007/s00296-022-05245.
     PubMed     Abstract available
     
     
     
115. SIEMPIS T, Tsakiris C, Anastasia Z, Alexiou GA, et al
     Radiological assessment and surgical management of cervical spine involvement in patients with rheumatoid arthritis.
     Rheumatol Int. 2022 Nov 15. pii: 10.1007/s00296-022-05239.
     PubMed     Abstract available
     
     
     
116. OUARDI NE, Maghraoui AE, Djossou HJ, Taoubane L, et al
     Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.
     Rheumatol Int. 2022 Nov 5. pii: 10.1007/s00296-022-05237.
     PubMed     Abstract available
     
     
     
117. NUNE A, Barman B, Sapkota HR, Ish P, et al
     Nanotechnology applications in rheumatology.
     Rheumatol Int. 2022;42:1883-1891.
     PubMed     Abstract available
     
     
     
118. GASTEIGER C, Scholz U, Petrie KJ, Dalbeth N, et al
     A bio-what? Medical companions' perceptions towards biosimilars and information needs in rheumatology.
     Rheumatol Int. 2022;42:1993-2002.
     PubMed     Abstract available
     
     
     October 2022
119. BLANKEN AB, Raadsen R, Agca R, van Sijl AM, et al
     Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients.
     Rheumatol Int. 2022 Oct 21. pii: 10.1007/s00296-022-05226.
     PubMed     Abstract available
     
     
     
120. MEDRADO LN, Mendonca MLM, Budib MB, Oliveira-Junior SA, et al
     Effectiveness of aquatic exercise in the treatment of inflammatory arthritis: systematic review.
     Rheumatol Int. 2022;42:1681-1691.
     PubMed     Abstract available
     
     
     
121. ILGEN U, Karadag O, Emmungil H, Kucuksahin O, et al
     Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
     Rheumatol Int. 2022;42:1797-1806.
     PubMed     Abstract available
     
     
     September 2022
122. REN J, Ding Y, Zhao J, Sun Y, et al
     Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis.
     Rheumatol Int. 2022 Sep 27. pii: 10.1007/s00296-022-05219.
     PubMed     Abstract available
     
     
     
123. KOSTER F, Lopes Barreto D, Nair SC, Kok MR, et al
     Defining the care delivery value chain and mapping the patient journey in rheumatoid arthritis.
     Rheumatol Int. 2022 Sep 23. pii: 10.1007/s00296-022-05215.
     PubMed     Abstract available
     
     
     
124. HUANG G, Wu L, Mei Z, Yao D, et al
     Rheumatoid meningitis without a history of rheumatoid arthritis: a case report and literature review.
     Rheumatol Int. 2022 Sep 20. pii: 10.1007/s00296-022-05209.
     PubMed     Abstract available
     
     
     
125. ATALAR E, Yurdakul FG, Gok K, Guler T, et al
     Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).
     Rheumatol Int. 2022 Sep 18. pii: 10.1007/s00296-022-05207.
     PubMed     Abstract available
     
     
     
126. SWIECKA M, Paluch L, Pietruski P, Maslinska M, et al
     Shear wave elastography as a potential additional diagnostic tool in primary Sjogren's syndrome: an observational study.
     Rheumatol Int. 2022;42:1579-1587.
     PubMed     Abstract available
     
     
     
127. LENDREM DW, Tarn JR, Collins A, Wason J, et al
     Why stratification is important in primary Sjogren's syndrome.
     Rheumatol Int. 2022;42:1661-1662.
     PubMed    
     
     
     August 2022
128. JAIN A, Joseph S, James J, James TS, et al
     Delay in diagnosis of rheumatoid arthritis: reasons and trends over a decade.
     Rheumatol Int. 2022 Aug 23. pii: 10.1007/s00296-022-05187.
     PubMed     Abstract available
     
     
     
129. PARASKEVI VV, Aliki VI, Antigone P, Zoi T, et al
     Orbital myositis in systemic lupus erythematosus: a case-based review.
     Rheumatol Int. 2022;42:1453-1460.
     PubMed     Abstract available
     
     
     
130. SILVA EV, Almeida LY, Bortoletto KC, Quero IB, et al
     Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjogren's syndrome: a comparative study.
     Rheumatol Int. 2022;42:1411-1421.
     PubMed     Abstract available
     
     
     
131. AL-EZZI M, Tappuni AR, Khan KS
     The impact of Sjgren's syndrome on the quality of sexual life of female patients in the UK: a controlled analysis.
     Rheumatol Int. 2022;42:1423-1429.
     PubMed     Abstract available
     
     
     July 2022
132. KOUGKAS N, Dara A, Pagkopoulou E, Dimitriadou A, et al
     Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.
     Rheumatol Int. 2022 Jul 18. pii: 10.1007/s00296-022-05166.
     PubMed     Abstract available
     
     
     
133. HAN P, Sun C, Zhang Y, Yan J, et al
     Sjogren's syndrome with adult-onset Still's disease: an overlap syndrome?
     Rheumatol Int. 2022;42:1281-1285.
     PubMed     Abstract available
     
     
     June 2022
134. BOYADZHIEVA V, Tachkov K, Stoilov N, Mitov K, et al
     Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
     Rheumatol Int. 2022 Jun 27. pii: 10.1007/s00296-022-05163.
     PubMed     Abstract available
     
     
     
135. INGRAM T, Sengupta R, Standage M, Barnett R, et al
     Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review.
     Rheumatol Int. 2022 Jun 8. pii: 10.1007/s00296-022-05142.
     PubMed     Abstract available
     
     
     May 2022
136. HOQUE A, Steultjens M, Dickson DM, Hendry GJ, et al
     Patients' and clinicians' perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index.
     Rheumatol Int. 2022 May 27. pii: 10.1007/s00296-022-05147.
     PubMed     Abstract available
     
     
     
137. POPOVA V, Geneva-Popova M, Kraev K, Batalov A, et al
     Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis.
     Rheumatol Int. 2022 May 26. pii: 10.1007/s00296-022-05113.
     PubMed     Abstract available
     
     
     
138. ZEKIC T, Benic MS, Radic M
     Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
     Rheumatol Int. 2022 May 23. pii: 10.1007/s00296-022-05143.
     PubMed     Abstract available
     
     
     April 2022
139. KARABULUT Y, Gezer HH, Esen S, Esen I, et al
     Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.
     Rheumatol Int. 2022 Apr 25. pii: 10.1007/s00296-022-05132.
     PubMed     Abstract available
     
     
     
140. PAPPAS DA, Brittle C, Concoff A, Holman AJ, et al
     Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
     Rheumatol Int. 2022 Apr 21. pii: 10.1007/s00296-022-05122.
     PubMed     Abstract available
     
     
     
141. FEUCHTENBERGER M, Kovacs MS, Eder A, Nigg A, et al
     Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis.
     Rheumatol Int. 2022 Apr 16. pii: 10.1007/s00296-022-05123.
     PubMed     Abstract available
     
     
     
142. YOSHII I, Sawada N, Chijiwa T
     Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
     Rheumatol Int. 2022 Apr 11. pii: 10.1007/s00296-022-05124.
     PubMed     Abstract available
     
     
     
143. RODERE M, Pereira B, Soubrier M, Fayet F, et al
     Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis.
     Rheumatol Int. 2022 Apr 7. pii: 10.1007/s00296-022-05090.
     PubMed     Abstract available
     
     
     
144. YOSHIMURA M, Fujieda Y, Sugawara M, Kono M, et al
     Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case-control study.
     Rheumatol Int. 2022 Apr 6. pii: 10.1007/s00296-022-05121.
     PubMed     Abstract available
     
     
     
145. JEON YH, Lim DH, Choi SW, Choi SJ, et al
     A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
     Rheumatol Int. 2022;42:743-748.
     PubMed     Abstract available
     
     
     
146. ZHANG X, Yang Q, Yu H, Yin F, et al
     Bibliometric analysis of the global literature productivity of adult-onset Still's disease (2011-2020).
     Rheumatol Int. 2022;42:707-716.
     PubMed     Abstract available
     
     
     March 2022
147. SKACELOVA M, Nekvindova L, Mann H, Zavada J, et al
     The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.
     Rheumatol Int. 2022 Mar 26. pii: 10.1007/s00296-021-05072.
     PubMed     Abstract available
     
     
     
148. NAKAYAMA Y, Watanabe R, Murakami K, Murata K, et al
     Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
     Rheumatol Int. 2022 Mar 10. pii: 10.1007/s00296-021-05086.
     PubMed     Abstract available
     
     
     
149. KABEERDOSS J, Sandhya P, Kurien BT, Scofield RH, et al
     In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
     Rheumatol Int. 2022;42:545-551.
     PubMed     Abstract available
     
     
     February 2022
150. SKRZYPKOWSKA M, Stasiak M, Sakowska J, Chmiel J, et al
     Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.
     Rheumatol Int. 2022 Feb 18. pii: 10.1007/s00296-022-05103.
     PubMed     Abstract available
     
     
     
151. SWAIN N, Tripathy A, Padhan P, Raghav SK, et al
     Toll-like receptor-7 activation in CD8+ T cells modulates inflammatory mediators in patients with rheumatoid arthritis.
     Rheumatol Int. 2022 Feb 10. pii: 10.1007/s00296-021-05050.
     PubMed     Abstract available
     
     
     
152. QIN L, Zhang Y, Yang X, Luo Q, et al
     Cardiac involvement in primary Sjgren's syndrome.
     Rheumatol Int. 2022;42:179-189.
     PubMed     Abstract available
     
     
     January 2022
153. WILK M, Losinska K, Pripp AH, Korkosz M, et al
     Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
     Rheumatol Int. 2022 Jan 31. pii: 10.1007/s00296-021-05070.
     PubMed     Abstract available
     
     
     
154. PSALTIS D, Settas L, Georgiadis A, Koukli E, et al
     The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
     Rheumatol Int. 2022 Jan 29. pii: 10.1007/s00296-021-05073.
     PubMed     Abstract available
     
     
     
155. HASAN AA, Reimann F, Veeger NJGM, Bergstra SA, et al
     Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry.
     Rheumatol Int. 2022 Jan 27. pii: 10.1007/s00296-021-05060.
     PubMed     Abstract available
     
     
     
156. KOSTURKOVA MB, Mihaylova GM, Shivacheva TK, Radanova MA, et al
     Association of C1q gene cluster variants with rheumatoid arthritis: a pilot study.
     Rheumatol Int. 2022 Jan 13. pii: 10.1007/s00296-022-05089.
     PubMed     Abstract available
     
     
     
157. KONSTANTONIS G, Singh KV, Sfikakis PP, Jamthikar AD, et al
     Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients.
     Rheumatol Int. 2022 Jan 11. pii: 10.1007/s00296-021-05062.
     PubMed     Abstract available
     
     
     
158. VIDEM V, Hoff M, Liff MH
     Use of the Behavioral Regulation in Exercise Questionnaire-2 to assess motivation for physical activity in persons with rheumatoid arthritis: an observational study.
     Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05079.
     PubMed     Abstract available
     
     
     
159. LAROCHE M, Degboe Y, Constantin A
     Sjogren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case-control study.
     Rheumatol Int. 2022 Jan 9. pii: 10.1007/s00296-021-05074.
     PubMed     Abstract available
     
     
     
160. TAYLAN A
     Rituximab therapy in pericarditis associated with rheumatoid arthritis.
     Rheumatol Int. 2022 Jan 5. pii: 10.1007/s00296-021-05080.
     PubMed     Abstract available
     
     
     
161. CHEN X, Hu QY, Wang M, Jia J, et al
     Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
     Rheumatol Int. 2022;42:149-157.
     PubMed     Abstract available
     
     
     December 2021
162. FRANKOWSKI M, Swierkot J, Gomulkiewicz M, Korman L, et al
     Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
     Rheumatol Int. 2021 Dec 6. pii: 10.1007/s00296-021-05059.
     PubMed     Abstract available
     
     
     
163. BAICUS C
     The stratification of primary Sjogren's syndrome: is it really solving the problem?
     Rheumatol Int. 2021;41:2241.
     PubMed    
     
     
     November 2021
164. BALCHIN C, Tan AL, Wilson OJ, McKenna J, et al
     Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study.
     Rheumatol Int. 2021 Nov 30. pii: 10.1007/s00296-021-05054.
     PubMed     Abstract available
     
     
     
165. ROMERA BAURES M, Seoane-Mato D, Alegre-Sancho JJ, Leon L, et al
     Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
     Rheumatol Int. 2021 Nov 16. pii: 10.1007/s00296-021-05043.
     PubMed     Abstract available
     
     
     
166. SERBAN A, Mihai A, Dima A, Balaban DV, et al
     The impact of the COVID-19 pandemic on patients with primary Sjogren syndrome.
     Rheumatol Int. 2021;41:1933-1940.
     PubMed     Abstract available
     
     
     
167. DARDER A, Losada Lopez I, Gomez-Bellvert C, Rodriguez A, et al
     Pulmonary nodular lymphoid hyperplasia and Sjogren's syndrome: a case report and literature review.
     Rheumatol Int. 2021;41:2041-2044.
     PubMed     Abstract available
     
     
     
168. PRIORI R, Giardina F, Izzo R, Gattamelata A, et al
     Resilience in women with primary Sjogren's syndrome.
     Rheumatol Int. 2021;41:1987-1994.
     PubMed     Abstract available
     
     
     October 2021
169. DE COCK D, Buckinx E, Pazmino S, Bertrand D, et al
     Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study.
     Rheumatol Int. 2021 Oct 23. pii: 10.1007/s00296-021-05020.
     PubMed     Abstract available
     
     
     
170. WOLKORTE R, Heesink L, Kip MMA, Koffijberg H, et al
     Monitoring of rheumatoid arthritis: a patient survey on disease insight and possible added value of an innovative inflammation monitoring device.
     Rheumatol Int. 2021 Oct 21. pii: 10.1007/s00296-021-05026.
     PubMed     Abstract available
     
     
     
171. MORALES-ETCHEGARAY I, Garcia-Carrasco M, Munguia-Realpozo P, Mendoza-Pinto C, et al
     Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.
     Rheumatol Int. 2021 Oct 5. pii: 10.1007/s00296-021-05013.
     PubMed     Abstract available
     
     
     
172. USKUDAR CANSU D, Uskudar Teke H, Korkmaz C
     Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
     Rheumatol Int. 2021;41:1803-1810.
     PubMed     Abstract available
     
     
     
173. MITTAL GK, Mittal S, Kaur H, Stephen SR, et al
     Anti-Sjogren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjogren's syndrome waiting to be unveiled? A case series and review of literature.
     Rheumatol Int. 2021;41:1855-1866.
     PubMed     Abstract available
     
     
     September 2021
174. BELANI PJ, Kavadichanda CG, Negi VS
     Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.
     Rheumatol Int. 2021 Sep 29. pii: 10.1007/s00296-021-04994.
     PubMed     Abstract available
     
     
     
175. MELIKOGLU MA, Ataman S, Bodur H, Cay HF, et al
     Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
     Rheumatol Int. 2021 Sep 24. pii: 10.1007/s00296-021-04992.
     PubMed     Abstract available
     
     
     
176. ALMUTAIRI K, Nossent J, Preen DB, Keen H, et al
     The temporal association between hospital admissions, biological therapy usage and direct health care costs in rheumatoid arthritis patients.
     Rheumatol Int. 2021 Sep 18. pii: 10.1007/s00296-021-04985.
     PubMed     Abstract available
     
     
     
177. NAFFAA ME, Hassan F, Golan-Cohen A, Merzon E, et al
     Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study.
     Rheumatol Int. 2021 Sep 16. pii: 10.1007/s00296-021-04989.
     PubMed     Abstract available
     
     
     
178. BARTELS LE, Ammitzboll C, Andersen JB, Vils SR, et al
     Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
     Rheumatol Int. 2021 Sep 2. pii: 10.1007/s00296-021-04972.
     PubMed     Abstract available
     
     
     
179. COLLINS A, Lendrem D, Wason J, Tarn J, et al
     Revisiting the JOQUER trial: stratification of primary Sjogren's syndrome and the clinical and interferon response to hydroxychloroquine.
     Rheumatol Int. 2021;41:1593-1600.
     PubMed     Abstract available
     
     
     
180. GEHIN JE, Klaasen RA, Norli ES, Warren DJ, et al
     Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort.
     Rheumatol Int. 2021;41:1657-1665.
     PubMed     Abstract available
     
     
     August 2021
181. GONZALEZ DA, Bianchi ML, Salgado PA, Armada M, et al
     Disease activity and subcutaneous nodules are associated to severe periodontitis in patients with rheumatoid arthritis.
     Rheumatol Int. 2021 Aug 22. pii: 10.1007/s00296-021-04974.
     PubMed     Abstract available
     
     
     
182. ZHAO SS, Nikiphorou E, Young A, Kiely PDW, et al
     Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis study.
     Rheumatol Int. 2021 Aug 16. pii: 10.1007/s00296-021-04931.
     PubMed     Abstract available
     
     
     
183. MACIVER A, Hollinger H, Carolan C
     Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review.
     Rheumatol Int. 2021;41:1399-1418.
     PubMed     Abstract available
     
     
     July 2021
184. SOBEJANA M, van den Hoek J, Metsios GS, Kitas GD, et al
     Cardiorespiratory fitness and physical activity in people who have rheumatoid arthritis at an increased risk of cardiovascular disease: a cross-sectional study.
     Rheumatol Int. 2021 Jul 31. pii: 10.1007/s00296-021-04903.
     PubMed     Abstract available
     
     
     
185. ZURA N, Vukorepa M, Jurak I, Peric P, et al
     Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
     Rheumatol Int. 2021 Jul 28. pii: 10.1007/s00296-021-04959.
     PubMed     Abstract available
     
     
     
186. BARIK RR, Bhatt LK
     Emerging epigenetic targets in rheumatoid arthritis.
     Rheumatol Int. 2021 Jul 26. pii: 10.1007/s00296-021-04951.
     PubMed     Abstract available
     
     
     
187. JOHNSTONE G, Treharne GJ, Fletcher BD, Lamar RSM, et al
     Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.
     Rheumatol Int. 2021 Jul 23. pii: 10.1007/s00296-021-04952.
     PubMed     Abstract available
     
     
     
188. MULLER K, Kuipers JG, Weis J, Fischer I, et al
     Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies.
     Rheumatol Int. 2021 Jul 16. pii: 10.1007/s00296-021-04948.
     PubMed     Abstract available
     
     
     
189. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
     Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
     Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
     PubMed     Abstract available
     
     
     
190. NAKAJIMA T, Watanabe R, Hashimoto M, Murata K, et al
     Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients.
     Rheumatol Int. 2021 Jul 9. pii: 10.1007/s00296-021-04944.
     PubMed     Abstract available
     
     
     
191. YAGIZ B, Coskun BN, Pehlivan Y, Dalkilic E, et al
     In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
     Rheumatol Int. 2021 Jul 5. pii: 10.1007/s00296-021-04939.
     PubMed     Abstract available
     
     
     
192. CHEVALLARD M, Belloli L, Ughi N, Adinolfi A, et al
     Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting.
     Rheumatol Int. 2021;41:1253-1261.
     PubMed     Abstract available
     
     
     
193. MULLER R
     Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.
     Rheumatol Int. 2021;41:1189-1202.
     PubMed     Abstract available
     
     
     June 2021
194. OULKADI L, Rostom S, Hmamouchi I, El Hassani Sbai S, et al
     Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registry.
     Rheumatol Int. 2021 Jun 26. pii: 10.1007/s00296-021-04929.
     PubMed     Abstract available
     
     
     
195. GOMEZ-GALICIA DL, Aguilar-Castillo J, Garcia-Garcia C, Moctezuma-Rios JF, et al
     Qualitative validation of audiovisual educational material for use on rheumatoid arthritis patients.
     Rheumatol Int. 2021 Jun 19. pii: 10.1007/s00296-021-04921.
     PubMed     Abstract available
     
     
     
196. TANAKA K, Kimura E, Oryoji K, Mizuki SI, et al
     Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database.
     Rheumatol Int. 2021 Jun 6. pii: 10.1007/s00296-021-04889.
     PubMed     Abstract available
     
     
     
197. SEBASTIAN A, Woytala P, Madej M, Proc K, et al
     Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjogren's syndrome?
     Rheumatol Int. 2021;41:1125-1131.
     PubMed     Abstract available
     
     
     
198. WADE SD, Kyttaris VC
     Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
     Rheumatol Int. 2021;41:1115-1124.
     PubMed     Abstract available
     
     
     May 2021
199. FAYET F, Pereira B, Fan A, Rodere M, et al
     Therapeutic education improves rheumatoid arthritis patients' knowledge about methotrexate: a single center retrospective study.
     Rheumatol Int. 2021 May 29. pii: 10.1007/s00296-021-04893.
     PubMed     Abstract available
     
     
     
200. SOYSAL E, Ulutas F, Tepeli E, Kaymaz S, et al
     IL-23R gene polymorphisms in rheumatoid arthritis.
     Rheumatol Int. 2021 May 12. pii: 10.1007/s00296-021-04881.
     PubMed     Abstract available
     
     
     
201. BHATIA A, Kc M, Gupta L
     Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.
     Rheumatol Int. 2021;41:843-850.
     PubMed     Abstract available
     
     
     
202. MIGKOS MP, Kaltsonoudis E, Pelechas E, Drossou V, et al
     Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
     Rheumatol Int. 2021;41:903-909.
     PubMed     Abstract available
     
     
     
203. HEGEMAN MC, Schoemaker-Delsing JA, Luttikholt JTM, Vonkeman HE, et al
     Patient perspectives on how to improve education on medication side effects: cross-sectional observational study at a rheumatology clinic in The Netherlands.
     Rheumatol Int. 2021;41:973-979.
     PubMed     Abstract available
     
     
     
204. MANOJ M, Sahoo RR, Singh A, Hazarika K, et al
     Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
     Rheumatol Int. 2021;41:929-937.
     PubMed     Abstract available
     
     
     April 2021
205. KAESTNER S, Wolff HJ, Braeuer R, Kaestner P, et al
     Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis.
     Rheumatol Int. 2021 Apr 29. pii: 10.1007/s00296-021-04871.
     PubMed     Abstract available
     
     
     
206. MAEDA Y, Hirano T, Ebina K, Hara R, et al
     Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
     Rheumatol Int. 2021 Apr 26. pii: 10.1007/s00296-021-04862.
     PubMed     Abstract available
     
     
     
207. TONGA E, Williamson E, Srikesavan C, Ozen T, et al
     A hand exercise mobile app for people with rheumatoid arthritis in Turkey: design, development and usability study.
     Rheumatol Int. 2021 Apr 18. pii: 10.1007/s00296-021-04860.
     PubMed     Abstract available
     
     
     
208. LU H, Yao Y, Yang J, Zhang H, et al
     Microbiome-miRNA interactions in the progress from undifferentiated arthritis to rheumatoid arthritis: evidence, hypotheses, and opportunities.
     Rheumatol Int. 2021 Apr 15. pii: 10.1007/s00296-021-04798.
     PubMed     Abstract available
     
     
     
209. CHELLAMUTHU G, Muthu S, Khanna M, Khanna V, et al
     "Platelet-rich plasma holds promise in management of rheumatoid arthritis"-systematic review.
     Rheumatol Int. 2021 Apr 8. pii: 10.1007/s00296-021-04849.
     PubMed     Abstract available
     
     
     
210. ELZORKANY B, Mokbel A, Gamal SM, Hmamouchi I, et al
     Does smoking affect level of seropositivity in RA? A post-HOC global and inter-country analysis of COMORA cohort.
     Rheumatol Int. 2021;41:699-705.
     PubMed     Abstract available
     
     
     
211. DEY M, Zhao SS
     Google search data as a novel adjunct to patient and public involvement in rheumatology research.
     Rheumatol Int. 2021;41:771-779.
     PubMed     Abstract available
     
     
     
212. AKYOL A, Kocyigit BF
     Publication activity in the field of Sjogren's syndrome: a ten-year Web of Science based analysis.
     Rheumatol Int. 2021;41:763-769.
     PubMed     Abstract available
     
     
     March 2021
213. MASLINSKA M, Manczak M, Kwiatkowska B, Ramsperger V, et al
     IgA immunoglobulin isotype of rheumatoid factor in primary Sjogren's syndrome.
     Rheumatol Int. 2021;41:643-649.
     PubMed     Abstract available
     
     
     January 2021
214. ANGELOPOULOU F, Bogdanos D, Dimitroulas T, Sakkas L, et al
     Immune checkpoint inhibitor-induced musculoskeletal manifestations.
     Rheumatol Int. 2021;41:33-42.
     PubMed     Abstract available
     
     
     July 2020
215. ELGHAWY AA, Skopis M, Davis J, Bag-Ozbek A, et al
     Angiostrongyliasis infection masquerading as granulomatosis with polyangiitis: a case-based review.
     Rheumatol Int. 2020;40:1171-1176.
     PubMed     Abstract available
     
     
     
216. LI R, Wan Q, Chen P, Mao S, et al
     Tocilizumab treatment in Felty's syndrome.
     Rheumatol Int. 2020;40:1143-1149.
     PubMed     Abstract available
     
     
     
217. LEE SB, Choi H, Kim MK, Jung SM, et al
     Can antineutrophil cytoplasmic antibody positivity at diagnosis predict the poor outcomes of Sjogren's syndrome?
     Rheumatol Int. 2020;40:1063-1070.
     PubMed     Abstract available
     
     
     May 2020
218. PARK EH, Lee EY, Shin K, Kim HA, et al
     Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
     Rheumatol Int. 2020;40:791-798.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.